人骨髓白血病细胞Kasumi-3

细胞名称

人骨髓白血病细胞Kasumi-3

货物编码

BFN60810785

产品规格

T25培养瓶x1

1.5ml冻存管x2

细胞数量

1x10^6

1x10^6

保存温度

37℃

-198℃

运输方式

常温保温运输

干冰运输

安全等级

1

用途限制

仅供科研   3类

培养体系

DMEM高糖（hyclone SH3022.01）+10%FBS+1%三抗

培养温度

37℃

二氧化碳浓度

5%

简介

人骨髓白血病细胞Kasumi-3取自57岁男性供体

注释

Part of: MD Anderson Cell Lines Project.

Population: Japanese.

Doubling time: 55-60 hours (PubMed=8613429); ~3-4 days (DSMZ).

Omics: Protein expression by reverse-phase protein arrays.

Omics: SNP array analysis.

Omics: Transcriptome analysis.

Derived from sampling site: Bone marrow myeloblasts.

基因突变

HLA信息

/

STR信息

Amelogenin        X

CSF1PO        12

D3S1358        14,15

D5S818        13

D7S820        11,12

D8S1179        14,16

D13S317        11,12

D16S539        12

D18S51        12,13

D21S11        29

FGA        22,23

Penta D        8,11

Penta E        15,20

TH01        6

TPOX        8,11

vWA        16,17

参考文献

PubMed=8613429; DOI=10.1111/j.1349-7006.1996.tb00216.x

Asou H., Suzukawa K., Kita K., Nakase K., Ueda H., Morishita K., Kamada N.

Establishment of an undifferentiated leukemia cell line (Kasumi-3) with t(3;7)(q27;q22) and activation of the EVI1 gene.

Jpn. J. Cancer Res. 87:269-274(1996)

DOI=10.1016/B978-0-12-221970-2.50457-5

Drexler H.G.

The leukemia-lymphoma cell line factsbook.

(In) ISBN 9780122219702; pp.1-733; Academic Press; London (2001)

PubMed=14504097; DOI=10.1182ood-2003-02-0418

Taketani T., Taki T., Sugita K., Furuichi Y., Ishii E., Hanada R., Tsuchida M., Sugita K., Ida K., Hayashi Y.

FLT3 mutations in the activation loop of tyrosine kinase domain are frequently found in infant ALL with MLL rearrangements and pediatric ALL with hyperdiploidy.

Blood 103:1085-1088(2004)

PubMed=23955599; DOI=10.1038.2731

Kon A., Shih L.-Y., Minamino M., Sanada M., Shiraishi Y., Nagata Y., Yoshida K., Okuno Y., Bando M., Nakato R., Ishikawa S., Sato-Otsubo A., Nagae G., Nishimoto A., Haferlach C., Nowak D., Sato Y., Alpermann T., Nagasaki M., Shimamura T., Tanaka H., Chiba K., Yamamoto R., Yamaguchi T., Otsu M., Obara N., Sakata-Yanagimoto M., Nakamaki T., Ishiyama K., Nolte F., Hofmann W.K., Miyawaki S., Chiba S., Mori H., Nakauchi H., Koeffler H.P., Aburatani H., Haferlach T., Shirahige K., Miyano S., Ogawa S.

Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms.

Nat. Genet. 45:1232-1237(2013)

PubMed=28196595; DOI=10.1016/j.ccell.2017.01.005

Li J., Zhao W., Akbani R., Liu W., Ju Z., Ling S., Vellano C.P., Roebuck P., Yu Q., Eterovic A.K., Byers L.A., Davies M.A., Deng W., Gopal Y.N.V., Chen G., von Euw E.M., Slamon D.J., Conklin D., Heymach J.V., Gazdar A.F., Minna J.D., Myers J.N., Lu Y., Mills G.B., Liang H.

Characterization of human cancer cell lines by reverse-phase protein arrays.

Cancer Cell 31:225-239(2017)

PubMed=32180206; DOI=10.1007/s13577-020-00347-5

Kasai F., Asou H., Ozawa M., Kobayashi K., Kuramitsu H., Satoh M., Kohara A., Kaneko Y., Kawamura M.

Kasumi leukemia cell lines: characterization of tumor genomes with ethnic origin and scales of genomic alterations.

Hum. Cell 33:0-0(2020)